top of page
Rubik's Oncolinkage Platform / Tumor Driven Discovery
Rubik discovers therapeutic targets by identifying genomic “oncolinkage” — the tumor-driven dysregulation of otherwise silent genes.
Rubik's Binder Platform
Enables efficient lead generation for CAR-T and radioligand therapeutics.
bottom of page